drugset / Trial / NCT01486771
Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)
RandomizedFactorialOpen-labelTreatment
Summary
Intravitreal injections of pegaptanib will induce the regression of Proliferative Diabetic Retinopathy (PDR) and reduce the need for retinal photocoagulation.
Timeline
- Start
- 2007-11
- Primary completion
- 2013-08
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pegaptanib sodium | Aptamer | 0.3 mg | Intravitreal |